These results indicate that O-GlcNAcylation is important for tumor cell growth and cancer cells appear to be specifically susceptible to loss of OGT, suggesting that this enzyme may be a potential future therapeutic target in chemotherapy. The gene discussed is OGT; the disease is neoplasm.